Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 110 citing articles:

Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 358
The coming decade in precision oncology: six riddles
Adam Wahida, Lars Buschhorn, Stefan Fröhling, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 43-54
Closed Access | Times Cited: 139
Potential Role of the Gut Microbiome In Colorectal Cancer Progression
Jae-Ho Kim, Heung Kyu Lee
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 134
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta‐Caldarola, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 4, pp. 333-339
Closed Access | Times Cited: 79
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 32
Bifidobacterium modulation of tumor immunotherapy and its mechanism
Bo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 17
Neoadjuvant immunotherapy in primary and metastatic colorectal cancer
A Kanani, Torhild Veen, Kjetil Søreide
British journal of surgery (2021) Vol. 108, Iss. 12, pp. 1417-1425
Open Access | Times Cited: 100
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 96
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Patricia Iranzo, Ana Callejo, J.D. Assaf, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 52
Combination of Whole Genome Sequencing and Metagenomics for Microbiological Diagnostics
Srinithi Purushothaman, Marco Meola, Adrian Egli
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9834-9834
Open Access | Times Cited: 49
The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
Farzaneh Fakharian, Behnoush Asgari, Ali Nabavi-Rad, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 38
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Samar Al Bitar, Marwan El‐Sabban, Samer Doughan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1395-1426
Open Access | Times Cited: 36
Microbial metabolites in colorectal tumorigenesis and cancer therapy
Yali Liu, Harry Cheuk-Hay Lau, Jun Yu
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
Dávid Dóra, Syeda Mahak Zahra Bokhari, Kenan Aloss, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2769-2769
Open Access | Times Cited: 24
Microbiome influencers of checkpoint blockade–associated toxicity
Yinghong Wang, Robert R. Jenq, Jennifer A. Wargo, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 3
Open Access | Times Cited: 22
The Evolving Landscape of Fecal Microbial Transplantation
Tihong Shao, Ronald Hsu, Camelia Hacein-Bey, et al.
Clinical Reviews in Allergy & Immunology (2023) Vol. 65, Iss. 2, pp. 101-120
Open Access | Times Cited: 22
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
A new strategy for immunotherapy of microsatellite‐stable (MSS)‐type advanced colorectal cancer: Multi‐pathway combination therapy with PD‐1/PD‐L1 inhibitors
Lingli Cai, Anqi Chen, Dong Tang
Immunology (2024) Vol. 173, Iss. 2, pp. 209-226
Open Access | Times Cited: 13
Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines
Tikun Shan, Wendie Wang, Mengyu Fan, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 866-878
Closed Access | Times Cited: 12
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
Chengpei Zhu, Yunchao Wang, Ruijuan Zhu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Immune checkpoint inhibitors in colorectal cancer: limitation and challenges
Suying Yan, Wanting Wang, Zhiqiang Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Yiru Zhou, Yeye Kuang, Chan Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1947-1964
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top